CNRS UMR9196, Laboratory of Molecular Physiology and Pathology of Endogenous and Infectious Retroviruses, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
VIROXIS, Gustave Roussy, Villejuif, France.
Life Sci Alliance. 2024 Sep 5;7(11). doi: 10.26508/lsa.202402844. Print 2024 Nov.
Intercellular protein-protein interactions (PPIs) have pivotal roles in biological functions and diseases. Membrane proteins are therefore a major class of drug targets. However, studying such intercellular PPIs is challenging because of the properties of membrane proteins. Current methods commonly use purified or modified proteins that are not physiologically relevant and hence might mischaracterize interactions occurring in vivo. Here, we describe Cell-Int: a cell interaction assay for studying plasma membrane PPIs. The interaction signal is measured through conjugate formation between two populations of cells each expressing either a ligand or a receptor. In these settings, membrane proteins are in their native environment thus being physiologically relevant. Cell-Int has been applied to the study of diverse protein partners, and enables to investigate the inhibitory potential of blocking antibodies, as well as the retargeting of fusion proteins for therapeutic development. The assay was also validated for screening applications and could serve as a platform for identifying new protein interactors.
细胞间蛋白质-蛋白质相互作用 (PPIs) 在生物功能和疾病中起着关键作用。因此,膜蛋白是主要的药物靶点之一。然而,由于膜蛋白的特性,研究这种细胞间的 PPI 具有挑战性。目前的方法通常使用纯化或修饰的蛋白质,这些蛋白质与生理状态不相关,因此可能会错误描述体内发生的相互作用。在这里,我们描述了 Cell-Int:一种用于研究质膜 PPI 的细胞相互作用测定法。通过两种细胞群体之间的缀合形成来测量相互作用信号,其中每一种细胞群体都表达配体或受体。在这些环境中,膜蛋白处于其天然环境中,因此与生理状态相关。Cell-Int 已应用于多种蛋白质伙伴的研究,并能够研究阻断抗体的抑制潜力,以及融合蛋白的重定向用于治疗开发。该测定法也经过了筛选应用的验证,可作为识别新的蛋白质相互作用物的平台。